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Abstract
Background: The incidence of multiple primary malignant neoplasms increases with age and they
are encountered more frequently nowadays than before, the phenomenon is still considered to be
rare.
Case presentation: W e  r e p o r t  a  c a s e  o f  a  m a n  i n  w h o m  urinary bladder transitional cell
carcinoma, metachronous prostate adenocarcinoma and small cell lung carcinoma were diagnosed
within an eighteen-month period. The only known predisposing factor was that he was heavy
smoker (90–100 packets per year). The literature on the phenomenon of multiple primary
malignancies in a single patient is reviewed and the data is summarized.
Conclusion: It is important for the clinicians to keep in mind the possibility of a metachronous
(successive) or a synchronous (simultaneous) malignancy in a cancer patient. It is worthy
mentioning this case because clustering of three primary malignancies (synchronous and
metachronous) is of rare occurrence in a single patient, and, to our knowledge, this is the first
report this combination of three carcinomas appearing in the same patient.
Background
The phenomenon of multiple primary malignant neo-
plasms in the same individual was described firstly by Bill-
roth at the end of the 19th century [1]. Since then, several
cases of double or even triple primary malignant neo-
plasms have been reported. It is believed that multiple pri-
mary malignant neoplasms now occur more frequently
than before. Although, not uncommon, they occur more
often in elderly patients, as the incidence of malignancies
increases with age. The diagnosis of second primary neo-
plasms is rising as a result of prolonged survival of
patients treated for previous malignancy with alkylating
agents, topoisomerase II inhibitors, and/or radiother-
apy[2]. A review of the recent literature indicates clearly
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that they appear more frequently in the upper digestive
tract, respiratory system, head and neck region, or uro-
genital system; the reported incidence ranges from 2% to
10% [3].
In this report we present a patient who developed primary
bladder carcinoma and metachronous prostate and small
cell lung carcinoma (SCLC) within an eighteen-month
period. This combination of multiple primary carcino-
mas, to our knowledge, has never been reported in the
literature.
Case presentation
A 75-year old ex-smoker (90–100 packet per year) under-
went a transurethral resection of urinary bladder papil-
loma in February 2002. The histology of resected
specimen was papillary transitional cell carcinoma grade
II (Figure 1A). The tumor cells were positive for cytokera-
tin 7 (Figure 1B) and negative for cytokeratin 20. There
were no muscle fibers in the examined tissue. The ultra-
sound examination of the urogenital system revealed nod-
ular hyperplasia of the prostate. The tumor clinical stage
according to the American Cancer Committee U.I.C.C.
(1992) was Ta. Patient's cancer relapsed at the end of the
same year and he underwent a programmed transurethral
resection of the tumor, which proved to be papillary tran-
sitional cell carcinoma grade I-II. No lamina propria or
muscle invasion was detected. The patient was also treated
with intracystic infusion of bacille Calmette-Guerin
(BCG). Ten days later, because of urine retention, he
underwent transurethral resection of the prostate. Multi-
ple tissue fragments of total dimensions 4.5 × 3.5 × 2.2 cm
were examined histologically. Seven out of the 10 exam-
ined slides revealed foci of partially mucinous (Figure 2A)
adenocarcinoma of the prostate (the greatest measured
focus was 8.5 mm in maximum diameter), Gleason grade
II-III and Gleason score 5 (Figure 2A, B). Immunohisto-
chemical study was performed and showed strong positiv-
ity for Prostate Specific antigen (PSA) (Figure 2C)
whereas; no expression of carcinoembryonic antigen
(CEA) was detected in tumor cells. These findings con-
firmed the diagnosis of primary prostate adenocarcinoma.
The tumor's stage according to the 1997 TNM staging sys-
tem of prostatic adenocarcinoma was T1b. Serum prostate
specific antigen (PSA) levels were elevated (9 ng/mL)
before surgery. No additional surgical treatment was given
and at follow-up visits prostate specific antigen (PSA) lev-
els measurement and intracystic injection of BCG was
Microscopically, the extracted urinary bladder tissue parti- cles proved to be pieces of papillary transitional cell carci- noma grade II Figure 1
Microscopically, the extracted urinary bladder tissue parti-
cles proved to be pieces of papillary transitional cell carci-
noma grade II [A) hematoxylin and eosin × 40] and 
immunohistochemically they expressed cytokeratin 7 [B) 
cytokeratin 7 × 100].
Histologically, in most of the prostate tissue fragments were  recognized areas of, partially mucinous, adenocarcinoma of  the prostate, grade II-III Figure 2
Histologically, in most of the prostate tissue fragments were 
recognized areas of, partially mucinous, adenocarcinoma of 
the prostate, grade II-III (A. hematoxylin and eosin × 40, B: 
hematoxylin and eosin × 100). The tumor cells were strongly 
positive for PSA (C: PSA × 40).
The bronchial mucosa showed extensive invasion from small  blue round cells Figure 3
The bronchial mucosa showed extensive invasion from small 
blue round cells (A: hematoxylin and eosin × 100) that were 
positive for the neuroendocrine marker CD56 (B: × 200) 
and pan-cytokeratin (C: × 200).World Journal of Surgical Oncology 2005, 3:51 http://www.wjso.com/content/3/1/51
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Table 1: There are summarized the cases of triple or more malignancies, the first author, journal, year of publication and combination 
of neoplasms.
Year Author 1st Malignancy 2nd Malignancy 3rd Malignancy 4th Malignancy 5th Malignancy
1 1949 Crail H.W 
[6]
Thyroid Carcinoma Rectal Carcinoma Medulloblastoma
2 1974 Hamoudi 
A.B.[7]
Colon Carcinoma Thymus Carcinoma Skin Carcinoma Astrocytoma G3
3 1975 Ohsato K. 
[8]
Colon Carcinoma Astrocytoma G3 Duodenal Carcinoma
4 1976 Kawanami 
K. [9]
Ileum Carcinoma Glioblastoma Colon Carcinoma
5 1976 Rovinescu 
I.[4]
Clear Cell Carcinoma 
Of Kidney
Transitional Cell 
Carcinoma Of Bladder
Prostate Carcinoma
6 1979 Itoh H.[10] Colon Carcinoma Stomach Carcinoma Astrocytoma G3
7 1979 Mullen 
J.L.[11]
Hodgkin' Disease Squamous Cell 
Carcinoma Of Larynx
Squamous Cell 
Carcinoma In Esophagus
8 1979 Pinel J.[12] 7 Squamous Cell 
Carcinomas In 9 Years
9 1980 Cohen 
C.[13]
Multiple Cutaneous 
Squamous Cell 
Carcinomas
Multiple Cutaneous Basal 
Cell Carcinomas
Diffuse Poorly 
Differentiated 
Lymphocytic Lymphoma
10 1982 Friedman 
C.D. [14].
Breast Carcinoma Colon Carcinoma Glioblastoma In Brain
11 1983 Li F.P.[15] Colon Carcinoma Astrocytoma G3 Leukemia
12 1984 Haibach 
H.[16]
Thyroid Carcinoma Renal Carcinoma Duodenal Carcinoma
13 1985 Alessi E.[17] Multiple Sebaceous 
Tumors
Keratoacanthoma 3 Primary 
Adenocarcinomas Of 
Colon
14 1985 Kobayashi 
T. [18]
Uterus Carcinoma Stomach Carcinoma Breast Carcinoma Glioblastoma In Brain
15 1985 Megighian 
D.[19]
Squamous Cell 
Carcinoma Of Parotid
Squamous Cell 
Carcinoma Of Tongue
Squamous Cell 
Carcinoma Of Soft Palate
Squamous Cell 
Carcinoma Of Larynx
Squamous Cell 
Carcinoma Of 
Hypopharynx
16 1985 Staren 
E.D.[20]
Carcinoma Of Larynx Carcinoma Of Floor Of 
Mouth
Dual Primary 
Bronchogenic 
Carcinomas
17 1986 Craig 
D.M.[21]
Squamous Cell 
Carcinoma Of The Floor 
Of The Mouth
Adenocarcinoma Of Lung Squamous Cell 
Carcinoma Of Larynx
Squamous Cell 
Carcinoma Of The 
Tongue
18 1986 Ogasawara 
K.[22]
Breast Carcinoma Breast Carcinoma Lung Carcinoma Glioblastoma In Brain Thyroid Carcinoma
19 1987 Hayashi 
K.[23]
Colon Carcinoma Rectal Carcinoma Glioblastoma In Brain
20 1987 Kobayashi 
T.[24]
Uterus Carcinoma Stomach Carcinoma Glioblastoma In Brain
21 1988 Ohi H. [25] Skin Carcinoma Medulloblastoma Thyroid Carcinoma
22 1991 Baigrie 
R.J.[26]
7 Primary Carcinomas
23 1991 Solan 
M.J.[27]
Two Breast Carcinomas Thyroid Carcinoma Multiple Skin Carcinomas
24 1992 Melkert 
P.W. [28]
Squamous Cell 
Carcinoma Of Skin
Squamous Cell 
Carcinoma Of Vulva
Squamous Cell 
Carcinoma Of Vagina
Squamous Cell 
Carcinoma Of Anus
Squamous Cell 
Carcinoma Of Cervix 
Uteri
25 1992 Marcos 
Sanchez F. 
[29]
Colon Carcinoma Renal Carcinoma Breast Carcinoma
26 1993 Brugieres L.  
[30]
Soft Tissue Tumor Brain Tumor Thyroid Carcinoma Breast Carcinoma
27 1993 Kikuchi T. 
[31]
Glioblastoma Colon Carcinoma Colon Carcinoma
28 1993 Shiseki 
M.[32]
Skin Carcinoma Colon Carcinoma Glioblastoma In Brain
29 1994 Bumpers 
H.L.[33]
Squamous Cell 
Carcinoma Of Larynx
Squamous Carcinoma Of 
Lung
Adenocarcinoma Of 
Breast
Adenocarcinoma Of 
Colon
30 1994 Nishihara K. 
[34]
Papillary 
Adenocarcinoma Of 
Papilla Of Vater
Papillary Adenocarcinoma 
Of Common Bile Duct
Papillary 
Adenocarcinoma Of 
Pancreas
31 1995 Angeli-
Besson C. 
[35]
Chronic Myeloid 
Leukemia, Multiple 
Squamous Cell 
Carcinomas
32 1996 Hayashi 
T.[36]
Squamous Cell 
Carcinoma In Soft Palate
Squamous Cell 
Carcinoma In Larynx
Squamous Cell 
Carcinoma In Esophagus
33 1996 Nagane 
M.[37]
Tubular 
Adenocarcinoma Of 
Stomach
Transitional Cell 
Carcinoma Of Bladder
Glioblastoma In BrainWorld Journal of Surgical Oncology 2005, 3:51 http://www.wjso.com/content/3/1/51
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performed. In September of the same year, due to progres-
sively worsening dyspnea a computed tomography was
performed that revealed a mediastinal mass in conjunc-
tion to the right lung hilum and to the right main bron-
chus with maximum diameter of 9 cm. Bronchoscopy
showed a large mass which invaded the right main bron-
chus mucosa and extended to the carina. Histology of the
bronchial mucosal sample showed infiltration of lamina
propria by malignant cells (Figure 3A). Their immu-
nophenotype was: CD56 (+) (Figure 3B), Pan-Cytokeratin
(paranuclear dot stain positivity) (Figure 3C) and Leuko-
cyte Common Antigen negative. Combining the morpho-
logical and the immunohistochemical results, we
concluded that the patient was suffering from small cell
lung carcinoma (SCLC). The patient's stage was IIIB. Ten
days after the diagnosis was confirmed, the patient under-
went the first cycle of chemotherapy (Cisplatin and
Vepesid), during which he died from cardiac arrest due to
chemotherapy toxicity.
Discussion
We report a patient who developed three histologically
distinct malignancies, i.e. primary bladder carcinoma and
metachronous prostate and SCLC within an eighteen-
month period. There are several predisposing or causal
factors for each malignancy. For our patient there was
only one common causal factor, the fact that he was a
heavy smoker (90–100 packets per year). No other predis-
posing factor or a family history was found that might
have contributed to the development of these three malig-
nancies. The presence of bladder and prostate carcinomas
in the same patient is not a rare event. Chun [3] reported
that the rate of bladder carcinoma in patients with pros-
tate carcinoma is eighteen times higher (p < 0,01) and the
rate of prostate carcinoma in those with bladder carci-
noma is nineteen times higher (p < 0,01) than expected.
Although bladder and prostate carcinoma can coexist in
the same individual frequently enough, the rare event is
the appearance of a third malignancy. There is a case
report by Rovinescu et al [4] referring to a patient with
three primary malignancies. The first tumor was a clear
cell carcinoma of the kidney, which was followed by a
transitional cell carcinoma of the bladder and then by a
distinct adenocarcinoma of the prostate. More recently, in
2003, Satoh et al [5] also reported the same combination
of multiple primary malignancies in a patient. Our case is
the first one of an individual having these two primary
malignancies of the urogenital system and another tumor
of the lower respiratory tract.
Table 1 summarizes the cases with three or more primary
malignancies. As can be easily seen, although the appear-
ance of three primary malignancies in one patient is not
very common, should not be considered such a rare event.
Additionally, studying the existing bibliography, we
noticed that there is a little confusion regarding the terms
used, such as synchronous, simultaneous and meta-
chronous or successive neoplasms. All of these words have
to do with the time that the neoplasms are discovered and
have nothing to do with the time of their genesis. The
word synchronous is a Greek one that should refer to
neoplasms appearing in the same time. It is synonymous
to the word simultaneous and they are interchangeable.
Metachronous (meta- means after and -chronous is the
time) is also a Greek word referring to a neoplasm that is
discovered while there is already a known neoplasm in the
same patient. The word successive could be used equally
to metachronous.
34 1996 Nagane M. 
[37]
Papillary 
Adenocarcinoma Of 
Lung
Adenocarcinoma Of 
Rectum
Glioblastoma In Brain
35 1997 Potzsch 
C.[38]
Breast Carcinoma Small Cell Lung 
Carcinoma
Renal Cell Carcinoma Acute Myelomonocytic 
Leukemia
36 1997 Shan L.[39] 14 Foci Of Primary SCC, 
Esophagus, Oral Floor, 
Soft Palate, Uvula, 
Lingual Radix, Piriform 
Recess, Hypopharynx, 
Trachea, Lingual Body
37 1999 Cribier B. 
[40]
Eccrine Porocarcinoma Tricholemmal Carcinoma Multiple Squamous Cell 
Carcinomas
38 1999 Ramsay 
H.M.[41]
Acute Myeloid Leukemia Chronic Lymphocytic 
Leukemia
Basal Cell Carcinomas
39 1999 Schon 
M.P.[42]
Basal Cell Carcinomas Hairy Cell Leukemia Basal Cell Carcinomas
40 2000 Beswick 
S.J.[43]
Basal Cell Carcinomas Malignant Melanoma In 
Situ
Basal Cell Carcinomas
41 2001 Mukai [44] Stomach Carcinoma Duodenal Carcinoma Esophageal Cancer Renal Cancer Colon Carcinoma In Situ
42 2003 Satoh H.[5] Carcinoma Of Kidney Transitional Cell 
Carcinoma Of Bladder
Prostate Carcinoma
Table 1: There are summarized the cases of triple or more malignancies, the first author, journal, year of publication and combination 
of neoplasms. (Continued)World Journal of Surgical Oncology 2005, 3:51 http://www.wjso.com/content/3/1/51
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Conclusion
Summarizing, it is important for the clinicians to keep in
mind that the appearance of another tumor in a patient
suffering from cancer could be either a metastasis or
another malignancy and should always investigate the
possibility of a metachronous (successive) or a synchro-
nous (simultaneous) malignancy. Moreover, the combi-
nation of the three different neoplasms (bladder, prostate
and SCLC) in one patient, to the best of our knowledge,
has never been reported before.
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